25.7 C
Buenos Aires
jueves 28 marzo 2024 18:16 PM
Inicio Buscar

english version - Resultados de la búsqueda

Si no estás feliz con los resultados, por favor realiza otra búsqueda

Pharmabiz launches You Tube reports

English Version Pharmabiz, the leading specialist on the Latin American pharmaceutical and cosmetics industries, is expanding its journalistic output to include You Tube video reports. The two-minute micro-reports will be recorded on site at Pharmabiz’s editorial offices, and have the seal and support of the respected media outlet’s journalistic team. See channel. The idea is...

Argentine drugmakers buy bunch of Abbott brands

English Version The deals and acquisitions in the pharma industry continue even as the bells are about to ring for New Year. The deals and acquisitions in the pharma industry continue even as the bells are about to ring for New Year. Argentine drugmakers Microsules, led by the Breitman family, and Biosintex, led...

New player in the Pharma adhesives market

English Version Facundo Schiavone (ex Andreani) and Jorge Muixi (ex H.B. Fuller) have launched a new company in the Argentine market. Facundo Schiavone (ex Andreani) and Jorge Muixi (ex H.B. Fuller) have launched a new company in the Argentine market. With an initial investment of $10 million, the firm will focus on the specialist adhesives sector, catering for different industries,...

Marken (soon to be UPS) cuts the ribbon at new facilities...

English Version Pharmabiz was present as the clinical trials logistics company Marken cut the ribbons on a new operations centre yesterday. Pharmabiz was present as the clinical trials logistics company Marken cut the ribbons on a new operations centre yesterday. The company’s global CEO Wes Wheeler attended the event, along with its...

Dufour returns in the hands of home cleaning products

English Version Argentine men's deodorant and fragrance brand Dufour is returning in the hands of the owners of a classic home cleaning product. Argentine men's deodorant and fragrance brand Dufour is returning in the hands of the owners of a classic home cleaning product. The brand is being relaunched by local firm Villard & Louis, makers...

Argentine pharma companies looking abroad

English Version Argentine firms feeling the pinch from an ongoing recession at home are looking abroad for expansion. Argentine firms feeling the pinch from an ongoing recession at home are looking abroad for expansion. Several local firms are looking to enter new markets and create alliances, mainly in the areas of generics...

Traceability: new rules

English Version As predicted by Pharmabiz, Argentina's regulator ANMAT has introduced new rules for drugs traceability. Ruling number 10564, published in Argentina's governmental bulletin, merges previous lists of active ingredients that must be traced, and adds more. The measure updates lists published in 2011, eliminating close to 100 drugs listed in four rulings emitted...

Richmond continues regional expansion with new company in Uruguay

English Version Argentine drugmaker Richmond, led by Marcelo Figueiras, has informed the country's national securities commission that is has decided to register a limited company in Uruguay. Argentine drugmaker Richmond, led by Marcelo Figueiras, has informed the country's national securities commission that is has decided to register a limited company in Uruguay. The new...

Droguería del Sud opens new facilities

English Version Argentine president Mauricio Macri cut the ribbon at Droguería del Sud's new central distribution centre in the province of Buenos Aires. Argentine president Mauricio Macri cut the ribbon at Droguería del Sud's new central distribution centre in the province of Buenos Aires. Pharmabiz was present at the event, at which Drogería del Sud's president,...

Indian drugmakers focus on Latin America

English Version India’s phamaceutical industry continues to look for strategic allies in Latin America and seems to have its eyes on Peru. India’s phamaceutical industry continues to look for strategic allies in Latin America and seems to have its eyes on Peru. In Argentina, inroads had been made during the previous government’s administration, led by Cristina Fernández...

Colorcon: new CEO and projects

Colorcon has a new regional CEO. Now at the helm in South America is Rafael Falco, who was previously the company’s sales manager for the southern cone. English Version The multinational Colorcon, specialised in colourings and coatings for medicines, has a new regional CEO. Now at the helm in South America is Rafael Falco, who was previously the company’s sales...

Layoffs at AstraZeneca

Anglo-Swedish drugmaker AstraZeneca is laying off 100 employees in Argentina. Under new CEO Gustavo Mizraje, the local operation is making the cuts in the areas of administration and marketing English Version Anglo-Swedish drugmaker AstraZeneca is laying off 100 employees in Argentina, Pharmabiz has learned. Under new CEO Gustavo Mizraje, the local operation is making the cuts in the...

More layoffs at Biogen

English Version Global biotech firm Biogen continues to lay off staff in Argentina while rumours circulate that it might leave the country altogether. Global biotech firm Biogen continues to lay off staff in Argentina while rumours circulate that it might leave the country altogether. The latest news obtained by Pharmabiz is that the multinational...

Bayer event: focus on Latin America

English Version Bayer brought together a legion of Latin American journalists for a press conference in Buenos Aires to outline its plans for the continent and detail its performance in each country. Bayer brought together a legion of Latin American journalists for a press conference in Buenos Aires to outline its plans for...

Danish drugmaker lays off local director

Alberto Weder’s 15-year tenure at the helm of Danish drugmaker Lundbeck’s Argentine concern has been brought to an end. English version Alberto Weder’s 15-year tenure at the helm of Danish drugmaker Lundbeck’s Argentine concern has been brought to an end, Pharmabiz has learned. For the moment, finance director Enrique Alba Valle is acting...

Argentine biotech firm in crisis: debts and layoffs

Sources say the company is considering opening crisis prevention talks with Argentina’s Ministry of Work, but official spokesmen have denied this. English Version Argentine biotech firm Amega Biotech is facing financial difficulties and has begun making layoffs, Pharmabiz has learned. The company officially admitted to Pharmabiz that it has already cut 20 jobs from a total of 300 staff, but reliable...

AstraZeneca signs licensing deal

Swiss/British drugmaker AstraZeneca has closed a new licensing agreement with Argentine firm GP Pharm, Pharmabiz can exclusively reveal. English Version Swiss/British drugmaker AstraZeneca has closed a new licensing agreement with Argentine firm GP Pharm, Pharmabiz can exclusively reveal. The licensing and royalties agreement will see GP Pharm commercialise the injectable drugs Yectafer, Nubaína, Intrafer, Fentanilo and Remicit, which AZ produces at its plant in...

German drugmaker Stada buys Argentine generics producer

The post-Davos influx of foreign investment appears to be arriving more quickly than expected, starting with German drugmaker Stada's purchase of Argentine generics producer Vannier. English Version The post-Davos influx of foreign investment appears to be arriving more quickly than expected, starting with German drugmaker Stada's purchase of Argentine generics producer Vannier. See website. The transaction, completed...

Argentina signs Hepatitis C agreement

The Argentine health ministry today signed a u$s 5.4 million contract for the direct purchase of Hepatitis C treatments Sovaldi and Probirase. English Version The Argentine health ministry today signed a 72 million pesos ($5.4 million) contract for the direct purchase of Hepatitis C treatments Sovaldi and Probirase. The agreement was signed today by health minister Jorge Lemus. See...

Argentine firm buys German plant

Argentine businessman Jorge Braver has bought an oncology plant from German firm Fresenius Kabi's – specialists in infusion therapy and parenteral nutrition. English Version Argentine businessman Jorge Braver has bought an oncology plant from German firm Fresenius Kabi's – specialists in infusion therapy and parenteral nutrition. A strong man in the Cooperala industrial chamber who likes to hold his meetings...

Eurofarma buys Sanofi Argentine plant

English Version Brazilian firm Eurofarma has bought Sanofi’s plant in Lomas del Mirador, Argentina. The decision comes after a long process of due diligence in which the company, overseen by Mauricio Billi, looked closely at its figures. Brazilian firm Eurofarma has bought Sanofi’s plant in Argentina. The decision comes after a long process of due diligence in which the company, overseen...

Unilever sells Argentine brands and plant

The operation still needs the OK from the Argentine secretary of commerce but is expected to get the go-ahead. English Version Unilever sells Argentine brands and plant British-Dutch multinational Unilever has sold off a package of personal care brands, reliable market sources have told Pharmabiz. The move is intended to redress the monopolistic position...

Farré with the stars

English Version Fernando Farré loved being close to celebrities, and his position at Coty granted him access thanks to the company’s wide portfolio of fragrances associated with different stars. Fernando Farré loved being close to celebrity, and his position at Coty granted him access thanks to the company’s wide portfolio of fragrances associated with different stars. Pharmabiz published a gallery of...

Ex-Coty director arrested for wife’s murder

Although Farré left the company almost a year ago, the murder will without doubt have an impact on Coty’s image. English Version Fernando Farré, the former general manager of Coty Argentina, has been arrested after allegedly killing his wife, Claudia Schaefer, at their home in the Martindale gated community in Pilar. It is alleged that...

GSK’s malaria vaccine still a long way from roll-out in Africa

English Version Many media sources, including Argentina’s Clarín newspaper, reported in July that the vaccine had “been approved”, when in fact it had only received a “positive scientific opinion” from a European Medicines Agency commission. Contrary to excited media reports, GSK’s long-awaited malaria vaccine Mosquirix still faces a long process and significant hurdles...

Health minister in India

Argentine health minister Daniel Gollan is in India attempting to establish agreements with generics manufacturers, Pharmabiz has learned from reliable sources. English Version Argentine health minister Daniel Gollan is in India attempting to establish agreements with generics manufacturers, Pharmabiz has learned from reliable sources. The objective of the trip is to add...

Murray: global pharma perspectives

New Zealander Murray Aitken, Executive Director of IMS Institute for Healthcare Informatics, arrived in Argentina to give his global perspectives. English Version New Zealander Murray Aitken –Executive Director of IMS Institute for Healthcare Informatics- arrived in Argentina to give his global perspectives. Aitken explained which therapeutic areas were the most important and grew at the fastest...

Novartis sells local brand in Argentina

Swiss pharmaceutical company Novartis has sold its leading local anti-nausea brand Reliverán to Argentine firm Gador. English version Swiss pharmaceutical company Novartis has sold its leading local anti-nausea brand Reliverán to Argentine firm Gador. The transaction was closed in Buenos Aires on Friday April 24 and was confirmed to Pharmabiz by Víctor...

Layoffs and restructuring at GSK

English Version Pharma multinational GSK this week sat at the table at the Argentine Ministry of Work opposite the trade union for pharmaceutical sales representatives. The cause was the mandatory arbitration ordered by the Ministry after the company laid off 15 employees Pharma multinational GSK this week sat at the table at...

HLB buys AstraZeneca Rontag line

English Version Argentine firm HLB Pharma led by Hernán López Bernabó has acquired the Rontag line from British-Swedish multinational AstraZeneca for close to ten million pesos. Argentine firm HLB Pharma led by Hernán López Bernabó has acquired the Rontag line from British-Swedish multinational AstraZeneca for close to ten million pesos (USD...

Nestlé signs deal with Cassará

Swiss multinational Nestlé has closed a deal with Argentine pharma company Cassará to expand its presence in the local market. English Version Swiss multinational Nestlé has closed a deal with Argentine pharma company Cassará to expand its presence in the local market. The contract was signed last Tuesday at the headquarters of Nestlé Argentina. Present were Jason Stalker, Nestlé's regional CFO...

Phytomedicine approval in Uruguay

English Version Uruguayan firm Botica del Señor has launched a medicine derived from chamerion angustifolium to be used for the treatment of benign prostatic hyperplasia. Uruguayan firm Botica del Señor has launched a medicine derived from chamerion angustifolium, a plant commonly known as fireweed or rosebay willowherb, to be used for the treatment of benign prostatic hyperplasia. Pharmabiz...

Sidus reduces staff by 30%

Argentine pharmaceutical group Sidus has completed a round of voluntary redundancies covering all areas of the company. The deadline for take-up was Friday October 31. English Version Argentine pharmaceutical group Sidus has completed a round of voluntary redundancies covering all areas of the company. The deadline for take-up was Friday October 31. The company's objective was to reduce staff levels...

Savant opens new plant

The Argentine pharmaceutical company Savant has cut the ribbon at a new softgel capsule plant in the town of El Tío, Córdoba. English version In Córdoba– The Argentine pharmaceutical company Savant has cut the ribbon at a new softgel capsule plant in the town of El Tío, Córdoba. During a tour of...

Abbott acquires Recalcine

US pharma company Abbott has completed its acquisition of Chilean firm CFR Recalcine, doubling its presence in the Latin American generics market. English version US pharma company Abbott has completed its acquisition of Chilean firm CFR Recalcine, doubling its presence in the Latin American generics market.  See press release Abbott secured more than 99% of CFR’s common stock via a takeover...

Evolución de Pharmabiz

(English Version) Evolución Pharmabiz nació en diciembre de 2007, como un blog especializado en noticias de la industria y el retail farmacéutico de Argentina. Gracias a su posicionamiento diferencial –orientado a los ejecutivos y miembros del sector- y por contar con información propia sobre las principales novedades del mercado local, consolidó una...

Roemmers signs license for Menarini line

Argentina's Roemmers group has signed an agreement to take on most of the products belonging to Italian pharmaceutical firm Menarini, which abandoned Argentina in April. English version Argentina's Roemmers group has signed an agreement to take on most of the products belonging to Italian pharmaceutical firm Menarini, which abandoned Argentina...

Ferring sold Dupomar to Investi

The Swedish laboratory Ferring has sold the Dupomar line, which they had acquired ten years before, to the national company Investi. English version The Swedish laboratory Ferring has sold the Dupomar line, which they had acquired ten years before, to the national company Investi. The $ 4 million deal comprises the sale of Calcio Base Dupomar, Citramar, Deltrox, Filotricin, Mar-V and Piroxicam. The transaction...

Argentine government adds three vaccines

Argentine president Cristina Fernández de Kirchner has announced the addition of three new vaccines to the country's official immunisation schedule at a cost of $82 million. English version Argentine president Cristina Fernández de Kirchner has announced the addition of three new vaccines to the country's official immunisation schedule at a cost of $82...

Bagó forms new company

Argentine company Bagó has entered a joint venture with Dutch firm Synthon. The new enterprise, Synthon Bagó, is to specialise in multiple sclerosis. English version Argentine company Bagó has entered a joint venture with Dutch firm Synthon. The new enterprise, Synthon Bagó, is to specialise in multiple sclerosis. The agreement, sealed in Amsterdam,...

GSK & Elea sell non-core products

The Argentinean laboratory Elea and the British company Phoenix –which is part of the firm GlaxoSmithKline – have sold many of their non-core products in Argentina. English version The Argentinean laboratory Elea and the British company Phoenix –which is part of the firm GlaxoSmithKline – have sold many of their non-core...

Menarini to cease operations in Argentina

The Italian laboratory Menarini has decided to close its operations in Argentina. The decision was announced yesterday at the Ministry of Labor after a meeting on previously announced layoffs. English version The Italian laboratory Menarini has decided to close its operations in Argentina. The company formally announced the decision yesterday at the Ministry of Labor after a meeting on previously...

GSK came out swinging

The British Company GSK has touched several sore spots in its latest annual report with strong statements about intellectual property, pricing controls, and emerging markets’ protectionist policies. English version The British Company GSK has touched several sore spots in its latest annual report with strong statements about intellectual property, pricing controls,...

Valeant – on a nosedive due to devaluation?

Pharmaceutical company B+L, now renamed Valeant, is downsizing on a major scale in Argentina.The first step came back in September when the company cut ties with Máximo Pförtner. English version Pharmaceutical company B+L, now renamed Valeant, is downsizing on a major scale in Argentina. The first step came back in September when the company cut...

Congress: prices, industry and more

Argentine president Cristina Fernández de Kirchner opened the 132nd assembly of the National Congress in Buenos Aires on Saturday, marking the start of the 2014 legislative sessions. English version  Argentine president Cristina Fernández de Kirchner opened the 132nd assembly of the National Congress in Buenos Aires on Saturday (March 1), marking the start of the 2014 legislative...

Savant: Corporate Bonds with Bancor, James, and Others

The national laboratory Savant revamped its name. The company that was founded by Mauro Bono now changed its name to “Savant” in a strategic reduction associated with simplicity. English Version The national laboratory Savant revamped its name. The company that was founded by Mauro Bono now changed its name to “Savant” in a strategic reduction associated with simplicity. However, Savant...

Dromex: new softgel plant

Julio Scardigli's Dromex Group has cut the ribbon on a new soft capsule plant at the recently-opened Ezeiza industrial estate in the province of Buenos Aires. English version Julio Scardigli's Dromex Group has cut the ribbon on a new soft capsule plant at the recently-opened Ezeiza industrial estate in the province...

Hané and Hernán Bernabó, allies

The noted Jorge Hané and the no less renowned pharmaceutical businessman Hernán López Bernabó signed an agreement between companies. English version The noted Jorge Hané and the no less renowned pharmaceutical businessman Hernán López Bernabó signed an agreement between companies. They both put their signatures so that the popular product Reduce Fat...

Capano, end to a stage in B.I

After  21  years in the  company, Fabio Capano leaves the German Boehringer Ingelheim as of January 2014. English version Fabio Capano leaves the German Boehringer Ingelheim as of January 2014. It  will  be  after  21  years in the  company  and the last  six months  as the main  responsible person for the South...

Pfizer – Another Woman at the Forefront

The American Pfizer has appointed Adriana Belardinelli as site manager of its manufacturing plant in Argentina. English version The American Pfizer has appointed Adriana Belardinelli as site manager of its manufacturing plant in Argentina. With this decision, the company has put two women in key positions to carry out the most...

Roemmers Launches Nutraceutical

Roemmers group launched a line of instant formulas named Nutri Baby through its laboratory Argentia. English version Roemmers group launched a line of instant formulas named Nutri Baby through its laboratory Argentia. This new business unit is based on the acquisition of the small local firm Nutry Baby which the company made about three years...

MSD: Dismissals Are Coming

The American company Merck announced a global initiative aiming to focus on R&D as well as cutting back on trade costs. English version The American company Merck announced a global initiative aiming to focus on R&D as well as cutting back on trade costs. In the context of that plan, it will dismiss 20% of its...

Milk: No More Nestlé?

Baby formula market is changing by leaps and bounds in the region. It is a constantly growing business on which mega companies have had their eyes over the last few years. English version Baby formula market is changing by leaps and bounds in the region. It is a constantly growing business...

GSK in the limelight over bribery allegations

Pharmaceutical company GSK is on tenterhooks after the Chinese  government accused it of being behind a massive corruption scandal. English version Pharmaceutical company GSK is on tenterhooks after the Chinese  government accused it of being behind a massive corruption scandal. It is suspected of paying bribes to doctors, hospitals and bureaucrats, among...

Cassará in 50-50 partnership with APOTEX

The national firm Laboratorios Cassará reached an agreement with the Canadian company Apotex in order to participate in its local operation. English version The national firm Laboratorios Cassará reached an agreement with the Canadian company Apotex in order to participate in its local operation. Therefore, the company which landed in Argentina in 2011 implementing...

Roemmers Opens Dermo-cosmetic Division

Roemmers Group continues to create new business units and to forge projects. This time, it gave shape to its division baptized Belleza y Salud -Beauty and Health. English version Roemmers Group continues to create new business units and to forge projects. This time, it gave shape to its division baptized Belleza y Salud...

LiquidCap: new capsules with liquid

The national laboratory Novocap is tying its boots to go out into the field with a cutting-edge and differentiated technology in the local market. English Version The national laboratory Novocap is tying its boots to go out into the field with a cutting-edge and differentiated technology in the local market....

IMS World Review: emerging countries, prices and more

The IMS World Review 2013 took place today at the Buenos Aires Auditorium in the Recoleta neighbourhood. The event had a special flavour this year because IMS is celebrating 40 years in Argentina. English version The IMS World Review 2013 took place today at the Buenos Aires Auditorium in the Recoleta neighbourhood. The event...

Maprimed, renegotiation and capital contribution

The leading producer of active pharmaceutical ingredients (APIs) in Argentina had adverse results in the 2012 business year that continued during the first quarter of 2013. English version The leading producer of active pharmaceutical ingredients (APIs) in Argentina had adverse results in the 2012 business year that continued during the first...

Valeant acquires Bausch + Lomb

The Canadian pharmaceutical company Valeant, agreed to acquire the laboratory specialized in ophthalmology Bausch & Lomb, owned by the Warburg Pincus fund. English version The Canadian pharmaceutical company Valeant, which sold its assets in Argentina in 2008, agreed to acquire the laboratory specialized in ophthalmology Bausch & Lomb, owned by the Warburg Pincus fund. In order to carry...

BMS nombra a country manager

Bilingual Version Las multis están dando cátedra de género. Luego de que Pfizer nombrara en la Argentina a Anne Nijs como country manager para la región que comprende Argentina, Paraguay y Uruguay, ahora la nortemericana BMS eligió a Florencia Davel como su country manager en el país. Ver artículo. Esta designación surge...

Pfizer: maduros y corporativos, en nueva estructura

Bilingual Version En Pfizer hubo una modificación de modelo de negocio y estructura para todos los países que forman parte de la unidad llamada Mercados Emergentes. El tablero de ajedrez se movió en la misma dirección que lo están haciendo la mayoría de las multis: por un lado ubican sus productos...

Takeda: sale Wolfgang, entra Kassis

Bilingual Version  Luego de ponerle el cinturón a la filial argentina, el laboratorio japonés Takeda designó a un nuevo número uno en el país. Se trata de Jack Kassis Makdsi, que viene desde Takeda Venezuela, donde cumplía el rol de director Comercial. El nuevo ejecutivo remplaza al alemán Wolfgang Schmidt que estuvo...

Baxter: dólar, foco y LATAM

Bilingual Version Después de que Baxter comprara a la sueca Gambro a nivel global en diciembre de 2012, la compañía está reorganizando su negocio en América Latina. Esta situación, sumada a otros problemas en los países de la región, redefinieron una nueva estructura operativa para la multi de origen norteamericano...

Takeda ¿achique o expansión?

Bilingual Version Mientras los reportes internacionales hablan de un avance de la japonesa Takeda en América Latina, en Argentina la compañía emprendió un camino de clara reducción. Es así que la firma mantiene una estrategia dispar en cada país del continente. Por un lado abrió recientemente una flamante filial en Ecuador...

Purissimus, fin de una historia

Bilingual Version Los telegramas del personal del laboratorio Purissimus que se considera despedido ya están en curso. En sintonía, el laboratorio que fuera símbolo de la producción y el desarrollo local en farma, está vacío y sin actividad bajo la única perspectiva de que el millonario edificio en el que supo...

Vino Witty, desde Londres

Bilingual Version El británico GlaxoSmithKline recibió en la Argentina a su CEO Andrew Witty, quien aterrizó especialmente para inaugurar un nuevo laboratorio de control de calidad y de desarrollo de producto. El británico GlaxoSmithKline recibió en la Argentina a su CEO Andrew Witty, quien aterrizó especialmente para inaugurar un nuevo laboratorio...

Bagó acuerda con MSD

Bilingual Version La norteamericana MSD y el argentino Bagó se pusieron de acuerdo. Cerraron un agreement comercial para la promoción de su línea de productos de cuidados primarios, como así también la venta de dos de sus marcas. Es así que a partir de marzo de 2013,  Bagó llevará adelante la promoción...

Farmacity: cambio de timón

Bilingual Version Sebastián Miranda, actual gerente general de supermercados Día está preparando sus petates para sentarse al frente del sillón principal de Farmacity. Con gran experiencia en el sector de retail, Miranda también formó parte de Eki Discount, en la función de gerente comercial. Por el momento Mario Quintana seguirá al mando...

Sinergium Biotech inauguró planta

(English Version) Hoy la presidenta de la nación Cristina Fernández de Kirchner cortó las cintas de la única planta de vacunas antigripales, estacionales y pandémicas del continente. La ceremonia fue en Garín bajo el techo del consorcio de empresas conformado por los nacionales de Elea, los suizos de Novartis y los...

Eurofarma levanta planta

(Versão em Português) (Bilingual Version) El laboratorio brasileño Eurofarma apunta a consolidar su presencia en la Argentina. Es así que en el término de ocho meses levantará una planta en Ituzaingó, al oeste del Gran Buenos Aires, para elaborar formas sólidas. Mientras tanto su proyecto de mayor escala en General Rodríguez también avanza...

Farmacity: 15 años, un antes y un después

Versão em Português English Version La historia tuvo su origen en los escritorios de la firma de consultoría McKinsey. Fue cuando el joven Mario Quintana estaba a cargo de diferentes investigaciones de mercado que apuntaban a encontrar ventanas de inversión para sus clientes. La historia tuvo su origen en los escritorios de...

Genomma engulle a Tafirol

La mexicana Genomma sigue sumando masa crítica en Argentina. La firma está a punto de quedarse con Tafirol, una emblemática línea del laboratorio nacional Sidus.  La adquisición se terminaría de concretar en el primer mes del 2013, momento en el que será definido el monto de la transacción. (Versão em Português) (Bilingual...

Alfaparf levanta planta en Garín

(Bilingual Version) La italiana Alfaparf invertirá u$s 6 millones para volver a fabricar productos de belleza capilar en la Argentina. Será en una nueva planta que montará en el Centro Industrial de Garín, y estaría terminada para marzo de 2013. Desde allí elaborará líquidos y semisólidos para sus formulaciones en líneas...

Sidus, cartel de venta

(Bilingual Version) El laboratorio nacional Sidus viene atravesando varios problemas financieros desde hace cerca de siete años, los que se profundizaron luego de la separación de su grupo accionario original. Ver proceso. Ahora y con un pasivo de u$s 40 millones, de los cuales u$s 14 millones corresponden a deuda con...

BI, reduce R&D en Argentina

(Bilingual Version) El alemán Boehringer Ingelheim se vio obligado a cerrar su centro de Investigación y desarrollo en el país. Y la decisión se enmarca en el estado de la economía global.  El laboratorio alemán Boehringer Ingelheim se vio obligado a cerrar su centro de Investigación y desarrollo en el país. Y...

Medix, ¿sigue el derrotero mexicano?

(Bilingual Version) El laboratorio mexicano Medix puso sus fichas en la Argentina para constituirse en cabeza de lanza para así expandirse en la región. Ver artículo. Sin embargo, el proyecto está teniendo varias contramarchas. Hace poco más de un mes redujo su fuerza de ventas un 36%, desvinculando a 9 visitadores y...

Mead Johnson, evento en Baires

(Bilingual Version) Los norteamericanos de Mead Johnson llegaron a Buenos Aires para reunirse con médicos y periodistas. Fue así que hoy miércoles 3 de octubre convocaron a la prensa especializada en el Hotel Hilton de Buenos Aires. Allí se hizo presente Colin Rudolph, vicepresidente de global medical affairs y chief medical...

Pierre Fabre, nuevo número uno

(Bilingual Version) El francés Stephane Labattut asumió desde este octubre como número uno de Pierre Fabre en la Argentina. Así está reemplazando a Luc Ottavioli quien actuó como director general de la filial local por 12 años. Labattut llegó en vuelo directo desde Turquía, país en el que ejerció como líder de...

Genomma bought Piecidex

English Version The mexican laboratorio Genomma is looking for new brands to reinforce its growth in the dermocosmetics and over the counter medicine business. Therefore, it recently acquired Piecidex from the national company Andrómaco. Mexican laboratory Genomma acquired Piecidex from the Argentine firm Andrómaco. In this way, the company that is steadily climbing...

J&J nuevo gerente general Cono Sur

English Version     Versão em Português  El brasilero Andre Mendes, ya está plenamente asentado en la filial que la norteamericana J&J tiene en Buenos Aires, Argentina. Así, desde el barrio de Belgrano, este joven ejecutivo de 39 años, tendrá asimismo la responsabilidad sobre Uruguay, Paraguay y Bolivia. Mendes, que viene de cumplir...

Pfizer: asume la única general manager mujer

Bilingual Version El laboratorio número uno del mundo está dando un paso distintivo. Sucede que Pfizer le está preparando el escritorio en su sede porteña de Virrey Loreto, a su nueva número uno. Se trata de Anne Nijs, una belga que forma parte de Pfizer desde 2001 y cuya última posición fue...

Pfizer acéfala: filial argentina con silla vacía

(Bilingual Version) Jesús Loreto, el ex número uno de Pfizer Argentina, Uruguay y Paraguay ya tomó su nuevo cargo en Nueva York. Es que ya se puso el sombrero como director de la división genéricos de Pfizer para los mercados emergentes. Mientras tanto, puertas adentro y puertas afuera de Pfizer Argentina corre...

IMS World Review: emergentes, escala y perspectivas

(Bilingual Version) Con cero grados en el termómetro se celebró hoy en Buenos Aires el IMS World Review Conference 2012 en el auditorio del Buenos Aires Design, que puertas adentro, también replicaba la temperatura bajo cero. Para ello se dio cita la industria farmacéutica local a través de laboratorios, droguerías, los principales...

Urufarma inauguró planta de hormonales

Bilingual Version El laboratorio uruguayo Urufarma inauguró esta semana una planta en la ciudad de Canelones. El propio presidente de Uruguay José Mujica se hizo presente para el corte de cintas. Según el diario El Observador, la inversión fue de u$s 20 millones y de ahora en más podrá lanzar al mercado...

BMS: se fue Penn, llegó Cook

Bilingual Version Los pases en la norteamericana BMS están más que activos. Por caso, Scott Cook fue designado como el nuevo jefe de la multi en la Argentina. El ejecutivo migró desde su lugar en los Estados Unidos en reemplazo del ex CEO en la región Elvin Penn. Elvin Penn, quien tenía asiento en Argentina como número uno de Argentina, Chile, Perú, Venezuela y...

Colombia: fallo contra Abbott por Kaletra

Bilingual version La justicia colombiana falló en contra del Laboratorio Abbott y el Ministerio de Salud de ese país en una demanda por el precio y la disponibilidad en el mercado de Kaletra, indicado para tratar el VIH-Sida. Según la revista Portafolio, El juez administrativo de Bogotá Ómar Borja Soto sostuvo...

Consorcio contra el Chagas

Bilingual version El benznidazol –la principal droga que se utiliza para el tratamiento del Chagas– será producido por un consorcio que reúne al Ministerio de Salud, al laboratorio Elea, al fabricante de materias primas Maprimed -propiedad del Grupo Chemo y de Roemmers- y a Mundo Sano. A todas ellas las...

Pfizer sustituye importaciones

Bilingual version La norteamericana Pfizer dio un paso estratégico y en línea con las políticas del gobierno nacional. Según un comunicado difundido por la compañía, Pfizer comenzó a producir localmente durante febrero pasado, productos terminados que hasta el momento eran importados por la corporación. Se trata de atorvastatina y pregabalina, que se...

Mamaderas: bye bye al bisfenol

Bilingual version La ANMAT prohibió la fabricación, importación y comercialización de biberones que contengan bisfenol A en la Argentina. La Disposición 1207/2012 publicada hoy lunes 5 de marzo en el Boletín Oficial entrará en vigencia mañana, día a partir del cual las empresas tendrán un plazo de 30 días hábiles para atenerse...

Bayer, ganancias y emergentes

Bilingual version En su informe anual publicado hoy, martes 28 de febrero de 2012, Bayer dio a conocer su performance a nivel global. Ver Resultados 2011. En el mismo se destaca el incremento del 90% en ganancias que obtuvo la compañía en 2011. Mientras tanto, su crecimiento en ventas, fue del...

OTC: nueva regulación de ANMAT

Bilingual version El organismo regulador de los medicamentos en la Argentina estableció mediante la disposición 753/2012 los nuevos lineamientos para los prospectos, etiquetas y rótulos de especialidades medicinales de venta libre. Con la entrada en vigencia de la presente disposición publicada hoy en el Boletín Oficial, los nuevos registros o las...

AZ: vuelta de rosca global y local

Bilingual version La compañía anglo sueca AstraZEneca se está reestructurando a nivel global. Ver Plan. Su iniciativa que tiene por objetivo lograr mejores resultados implicará el recorte de 7.300 posiciones en los próximos dos años, en todo el mundo. Sobre este tema la farmacéutica se expidió oficialmente en el día de ayer....

ANMAT: nuevos aranceles 2012

Bilingual version El organismo regulador de alimentos, medicamentos y tecnología médica de la Argentina estableció los nuevos aranceles para el presente año. A través de la disposición 578 aprobó los aranceles que regirán para los trámites efectuados ante la Administración Nacional de Medicamentos, Alimentos y Tecnología Médica. (Ver disposición) La ANMAT tomó esta medida...

Cruz Verde en Colombia: chilenos no paran

Bilingual version El propietario de la chilena Farmacias Cruz Verde –uno de los tres principales retailers de farmacia de ese país- llegó a un acuerdo con la cadena farmacéutica colombiana Farmasanitas. Según el diario La República de Colombia, la alianza consiste en la venta de un porcentaje no especificado de Farmasanitas a la...

Carrefour: bye bye a sus farmacias

Bilingual version La cadena francesa de supermercados Carrefour dejó sus farmacias de Argentina . Ver artículo diario La Nación. Es así que la compañía dio marcha atrás con su plan de abrir farmacias propias y que con bombos y platillos anunció durante 2007. Ver artículo. En ese momento la firma no le había renovado el...

Pancutan: de Purissimus a Grupo Mega

(Bilingual Version) Megapharma adquirió la marca de cicatrizantes Pancutan, ya que el portafolio de Purissimus pasó a ser de esta firma. El portafolio completo de la unidad de farma del nacional Purissimus pasó a la esfera del consorcio farmacéutico Megapharma. Ver video. Es así que la compañía propiedad de Grupo Roemmers,...

Novartis: elige Brasil, não Argentina

Bilingual version El laboratorio suizo Novartis busca seguir extendiendo su negocio en Latinoamérica. Y ahora sus ojos se posan  en Brasil. Así lo anunció Joe Jimenez, CEO de la compañía en una entrevista a la revista brasilera Valor Económico. “Brasil es uno de los principales países para la inversión de Novartis....

Justicia y ANMAT: multa a GSK $1 millón

Bilingual Version El juez Marcelo Aguinsky confirmó la resolución administrativa de la ANMAT que impone una multa de $400 mil (u$s 92,1 mil) al británico GSK, a causa de las irregularidades cometidas en ensayos clínicos de la vacuna pediátrica Synflorix. El juez en lo penal económico Marcelo Aguinsky confirmó la resolución administrativa...

Pierre Fabre, alerta por planta argentina

Bilingual version La crisis europea ya llegó a la Argentina. Es que el gobierno francés liderado por Nicolas Sarkozy le puso un freno a los reembolsos de la seguridad social. Fue así que su producto Structum indicado para la artrosis y la poliartrosis, ha dejado de percibir los reembolsos sociales desde el...
Mensaje
1
¡Escribinos!
Hola! Somos PHARMABIZ un diario de noticias. Solo si tenes noticias, envialas aquí. Gracias!